Ashraf Eassa
Long/short equity, contrarian, independent research, tech

Applied Micro: Warning Signs Too Loud To Ignore

Applied Micro (NASDAQ:AMCC) has done an absolutely phenomenal job spinning its X-Gene story to investors and analysts alike for the last year or so. Despite the fact that this product is likely to be uncompetitive and is woefully behind schedule, and despite the grandiose revenue ramp promises (multiple years out, of course) the company's X-Gene microserver processor venture is unlikely to be particularly profitable, investors have continued to buy this company on the X-Gene "dream".

However, this quarter investor and analysts alike were served a very harsh dose of reality in the form of a lackluster forward guide and more vague promises and claims with respect to the company's upcoming X-Gene product line. The sell-off in shares of...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details